Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Revenue	$ 654	$ 1,667	$ 1,657	$ 2,269
Cost of revenues	87	269	245	300
Gross profit	567	1,398	1,412	1,969
Sales and marketing expenses	40	47	55	108
General and administrative expenses	742	665	1,345	1,522
Research and development costs	145	172	322	384
Other operating income	0	(227)	0	(227)
Operating income (loss)	(360)	741	(310)	182
Gain (loss) from change in fair value of hybrid financial instruments	(628)	(433)	(1,173)	24,054
Gain (loss) from change in fair value of derivative liability - warrants	207	258	580	3,424
Gain (loss) from change in fair value of derivative liability - Series C and D preferred stock and debentures	107	55	244	1,998
Gain on extinguishment of Debt	4,247	0	4,247	0
Interest income	0	16	0	16
Net income	3,573	637	3,588	29,674
Deemed dividends on convertible preferred stock	0	(16)	0	(16)
Deemed dividends on convertible debentures	0	(681)	0	(681)
Net income (loss) available to common shareholders	3,573	(60)	3,588	28,977
Comprehensive income (loss):
Net income (loss)	3,573	637	3,588	29,674
Foreign currency adjustment	0	22	0	133
Comprehensive income (loss):	$ 3,573	$ 659	$ 3,588	$ 29,807
Net income (loss) per common share, basic and diluted:
Basic (in dollars per share)	$ 0.01	$ 0.00	$ 0.70	$ 0.14
Fully diluted (in dollars per share)	$ 0.009	$ 0.00	$ 0.63	$ 0.11
Weighted average number of common shares:
Basic (in shares)	359,568,430	270,512,776	351,339,588	215,354,974
Fully diluted (in shares)	398,000,130	308,944,476	389,771,288	253,786,674